Houte Hans van

Chief Financial Officer

Chief Financial Officer at Nurix Therapeutics, Inc., filing insider transactions between 2026-04-30 and 2026-05-05.

Total Purchases

—

0 transactions

Total Sales

$273K

3 transactions

Companies Traded

3 total filings

Active Since

2026-04-30

Last: 2026-05-05

Companies

Nurix Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-05-05	NRIX	Sale	13.5K	$16.58	$223K	38.2K	SEC ↗
2026-05-05	NRIX	Sale	582	$17.18	$10K	37.6K	SEC ↗
2026-04-30	NRIX	Sale	2,388	$16.65	$40K	51.6K